Patent classifications
C07C211/35
HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF
The present invention provides a high-purity arylsulfonic acid amine salt vinyl monomer which is an extremely industrially useful arylsulfonic acid monomer with excellent storage stability and amphiphilic solubility in both water and organic solvents, a simple and practical method for producing the same, a polyarylsulfonic acid amine salt which is a polymer thereof, and a method for producing the same. In the arylsulfonic acid amine salt vinyl monomer, a tertiary amine having 2 or 3 different substituents that each have 1 to 7 carbon atoms and also containing at least one or more of tertiary carbon or quaternary carbon or cyclic skeleton in the structure is applied to an amine moiety thereof, and in addition, a polyarylsulfonic acid amine salt having high purity in terms of sulfonation rate and polymerization conversion rate and a polymer thereof are used.
Process for hydrogenating toluenediamine (TDA) tar
Process for hydrogenating toluenediamine (TDA) tar containing TDA and high boilers relative to TDA, including the step of contacting the toluenediamine tar with a heterogeneous hydrogenation catalyst comprising at least one metal selected from the group consisting of Ni, Co, Ru, Pd, Pt on at least one catalyst support selected from the group consisting of carbon, TiO.sub.2 and ZrO.sub.2, and with hydrogen under hydrogenating conditions.
Process for hydrogenating toluenediamine (TDA) tar
Process for hydrogenating toluenediamine (TDA) tar containing TDA and high boilers relative to TDA, including the step of contacting the toluenediamine tar with a heterogeneous hydrogenation catalyst comprising at least one metal selected from the group consisting of Ni, Co, Ru, Pd, Pt on at least one catalyst support selected from the group consisting of carbon, TiO.sub.2 and ZrO.sub.2, and with hydrogen under hydrogenating conditions.
Propellane derivates and synthesis
Disclosed herein are compounds of the general Formula (I), and methods of synthesizing substituted bicyclo[1.1.1 jpentanes. The synthetic methods described herein use a [1.1.1]propellane, a Group VIII transition metal compound, a hydride source and a reagent that can contribute a substituent to form a substituted bicyclo[1.1.1]pentane, such as a compound of the general Formula (I).
Propellane derivates and synthesis
Disclosed herein are compounds of the general Formula (I), and methods of synthesizing substituted bicyclo[1.1.1 jpentanes. The synthetic methods described herein use a [1.1.1]propellane, a Group VIII transition metal compound, a hydride source and a reagent that can contribute a substituent to form a substituted bicyclo[1.1.1]pentane, such as a compound of the general Formula (I).
DIFLUOROALKYLCYCLOPROPYL AMINO ACIDS AND ESTERS, AND SYNTHESES THEREOF
The invention provides methods of synthesizing compounds in an asymmetric or enantioenriched fashion, wherein the compounds are useful intermediates in the synthesis of viral protease inhibitors.
DIFLUOROALKYLCYCLOPROPYL AMINO ACIDS AND ESTERS, AND SYNTHESES THEREOF
The invention provides methods of synthesizing compounds in an asymmetric or enantioenriched fashion, wherein the compounds are useful intermediates in the synthesis of viral protease inhibitors.
SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS
The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.
SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS
The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.
Crystalline fosaprepitant dicyclohexylamine salt and its preparation
Dicyclohexylamine salt of fosaprepitant (fosaprepitant DCHA), a process for preparing fosaprepitant DCHA, and a use of fosaprepitant DCHA in the preparation of pharmaceutically acceptable fosaprepitant dimeglumine with high purity is provided. Fosaprepitant dimeglumine is prepared by treating fosaprepitant DCHA with an acid to form fosaprepitant, followed by adding N-methyl-D-glucamine to fosaprepitant.